Avalyn Pharma Inc. Financials
AVLN
All currency values in $ millions unless otherwise noted
| Income Statement | DEC 2025 | DEC 2024 |
|---|---|---|
| Revenues | ||
| Revenue | $0 | $0 |
| Operating Income | -$91 | -$57 |
| Net Income | ||
| Net Income | -$85 | -$50 |
Peers
Biotechnology · Pick stocks to compare with AVLN
CompareIntrinsic value
Held by ETFs
AVLN is in 8 US ETFs. The largest of them, with AVLN's weight in each:
iShares Russell 2000 Growth ETFIWO0.02%of the fund
T. Rowe Price Small-Mid Cap ETFTMSL0.07%of the fund
Vanguard Russell 2000 Growth ETFVTWG0.02%of the fund
iShares U.S. Pharmaceuticals ETFIHE0.10%of the fund
State Street SPDR S&P Pharmaceuticals ETFXPH0.78%of the fund
T. Rowe Price Health Care ETFTMED0.18%of the fund
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
5 of 5 free stocks used today
Keep analysing AVLN
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.